Genetic variability in response to infection: Malaria and after

Genes and Immunity

Volumn 3, Issue 6, 2002, Pages 331-337

  Weatherall, David J ^a   Clegg, J B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Host pathogen interaction; Human evolution; Malaria; Murine malaria; Sickle cell anaemia; Thalassaemia

Indexed keywords

ANIMAL MODEL; GENETIC ANALYSIS; GENETIC RESISTANCE; GENETIC VARIABILITY; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; MALARIA; MOUSE; NONHUMAN; PLASMODIUM; POPULATION; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; ERYTHROCYTE; EVOLUTION; GENETIC DISORDER; GENETICS; HUMAN; INFECTION; PHYSIOLOGY;

MURINAE;

HEMOGLOBIN; HLA ANTIGEN;

ANIMALS; DISEASE MODELS, ANIMAL; ERYTHROCYTES; EVOLUTION; GENETIC DISEASES, INBORN; HEMOGLOBINS; HLA ANTIGENS; HUMANS; INFECTION; MALARIA; MICE; VARIATION (GENETICS);

EID: 0041626891     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363878     Document Type: Review

References (60)

1. Cooke GS, Hill AVS. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001; 2: 967-977.
2. Haldane JBS. The rate of mutation of human genes. Proc VIII Int Cong Genetics Hereditas 1949; 35: 267-273.
3. Lederberg J. J.B.S. Haldane (1949) on infectious disease and evolution. Genetics 1999; 153: 1-3.
4. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes. 4th edn. Blackwell Science: Oxford, 2001.
5. Huisman THJ, Carver MFH, Efremov GD. A Syllabus of Human Hemoglobin Variants. Sickle Cell Foundation: Augusta, GA, 1998.
6. Livingstone FB. Frequencies of Hemoglobin Variants. Oxford University Press: New York, Oxford, 1985.
7. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull WHO 2001; 79: 704-712.
8. Antonarakis SE, Boehm CD, Giardina PVJ, Kazazian HH. Non random association of polymorphic restriction sites in the b-globin gene complex. Proc Natl Acad Sci USA 1982; 79: 137-141.
9. Orkin SH, Kazazian Jr HH, Antonarakis SE et al. Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene cluster. Nature 1982; 296: 627-631.
10. Higgs DR, Wainscoat JS, Flint J et al. Analysis of the human α-globin gene cluster reveals a highly informative genetic locus. Proc Natl Acad Sci USA 1986; 83: 5165-5169.
11. Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. In: Higgs DR, Weatherall DJ (eds). Baillière's Clinical Haematology; 'Haemoglobinopathies'. Baillière Tindall and W.B. Saunders: London, 1998, pp 1-51.
12. Huisman THJ, Carver MFH, Baysal E. A Syllabus of Thalassemia Mutations. The Sickle Cell Anemia Foundation: Augusta, 1997.
13. Allison AC. Population genetics of abnormal haemoglobins and glucose-6-phosphate dehydrogenase deficiency. In: Jonxis JHP (ed). Abnormal Haemoglobins in Africa. Blackwell Scientific Publications: Oxford, 1965, p 365.
14. Hill AV, Allsopp CEM, Kwiatkowski D et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600.
15. Modiano D, Luoni G, Sirima BS et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 2001; 414: 305-308.
16. Flint J, Hill AVS, Bowden DK et al. High frequencies of α thalassaemia are the result of natural selection by malaria. Nature 1986; 321: 744-749.
17. O'Shaughnessy DF, Hill AVS, Bowden DK, Weatherall DJ, Clegg JB, with collaborators. Globin genes in Micronesia: origins and affinities of Pacific Island peoples. Am J Hum Genet 1990; 46: 144-155.
18. +-thalassaemia protects children against disease due to malaria and other infections. Proc Natl Acad Sci USA 1997; 94: 14736-14741.
19. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human β-globin gene cluster. Am J Hum Genet 1984; 36: 1239-1258.
20. Flint J, Harding RM, Clegg JB, Boyce AJ. Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Hum Genet 1993; 91: 91-117.
21. Fullerton SM, Harding RM, Boyce AJ, Clegg JB. Molecular and population genetic analysis of allelic sequence diversity at the human β globin locus. Proc Natl Acad Sci USA 1994; 91: 1805-1809.
22. Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G, Weatherall DJ. Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in α- and β-thalassemia. J Exp Med 1991; 173: 785-791.
23. Pasvol G, Weatherall DJ, Wilson RJ. Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum. Nature 1977; 270: 171-173.
24. Williams TN, Maitland K, Bennett S et al. High incidence of malaria in α-thalassaemic children. Nature 1996; 383: 522-525.
25. Rees DC, Williams TN, Maitland K, Clegg JB, Weatherall DJ. Alpha thalassemia is associated with increased soluble transferrin receptor levels. Brit J Haemat 1998; 103: 365-370.
26. Carlson J, Nash GB, Gabutti V, Al-Yaman F, Wahlgren M. Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood 1994; 84: 3909-3914.
27. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10: 224-228.
28. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in Blacks. N Engl J Med 1976; 295: 302-304.
29. Weatherall DJ. Host genetics and infectious disease. Parasitol 1996; 112: S23-S29.
30. Luzzatto L, Mehta A, Vulliamy T. Glucose 6-phosphate dehydrogenase. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds). The Metabolic and Molecular Basis of Inherited Disease. 8th edn. McGraw Hill: New York, 2001, pp 4517-4554.
31. Ruwende C, Khoo SC, Snow RW et al. Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-249.
32. Ganczakowski M, Town M, Bowden DK et al. Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (Southwestern Pacific). Am J Hum Genet 1995; 56: 294-301.
33. Mgone CS, Koki G, Paniu MM et al. Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea. Trans Roy Soc Trop Med Hyg 1996; 90: 228-231.
34. Genton B, Al-Yaman F, Mgone CS, Alexander N, Paniu MM, Alpers MP. Ovalocytosis and cerebral malaria. Nature 1995; 378: 564-565.
35. Allen SJ, O'Donnell A, Alexander NDE et al. Prevention of cerebral malaria in children in Papua New Guinea by Southeast Asian ovalocytosis band 3. Am J Trop Med Hyg 1999; 60: 1056-1060.
36. Hill AVS, Elvin J, Willis A et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360: 434-439.
37. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region is associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.
38. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
39. Knight JC, Udalova J, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
40. Aitman TJ, Cooper LD, Norsworthy PJ et al. Malaria susceptibility and CD36 mutation. Nature 2000; 405: 1015-1016.
41. Pain A, Urban BC, Kai O et al. A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 2001; 357: 1502-1503.
42. Fernandez-Reyes D, Craig AG, Kyes SA et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 1997; 6: 1357-1360.
43. Bellamy R, Kwiatkowski D, Hill AV. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans Roy Soc Trop Med Hyg 1998; 92: 312-316.
44. Modiano D, Petrarca V, Sirima BS et al. Different response to Plasmodium falciparum malaria in West African sympatric ethnic groups. Proc Natl Acad Sci USA 1996; 93: 13206-13211.
45. Fortin A, Belouchi A, Tam MF et al. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat Genet 1997; 17: 382-383.
46. Foote SJ, Burt RA, Baldwin SM et al. Mouse loci for malaria-induced mortality and the control of parasitaemia. Nat Genet 1997; 17: 380-381.
47. Fortin A, Cardon LR, Tam M, Skamene E, Stevenson MM, Gros P. Identification of a malaria new susceptibility locus (Char4) in recombinant congenic strains of mice. Proc Natl Acad Sci USA 2001; 98: 10793-10798.
48. s Senegal mutation. Am J Hum Genet 2002; 70: 207-223.
49. Tishkoff SA, Varkonyi R, Cahinhinan N et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 2001; 293: 455-462.
50. Volkman SK, Barry AE, Lyons EJ et al. Recent origin of Plasmodium falciparum from a single progenitor. Science 2001; 293: 482-484.
51. Rich SM, Ayala FJ. Population structure and recent evolution of Plasmodium falciparum. Proc Natl Acad Sci USA 2000; 97: 6994-7001.
52. Weatherall DJ, Clegg JB, Kwiatkowski D. The role of genomics in studying genetic susceptibility to infectious disease. Genome Res 1997; 7: 967-973.
53. Roy S. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999; 179: 187-191.
54. Bellamy R, Ruwende C, Corrah T et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-724.
55. Dean M, Carrington M, Winkler C et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862.
56. Kostrikis LG, Neumann AU, Thomson B et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 1999; 73: 10264-10271.
57. Martin MP, Dean M, Smith MW et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998; 282: 1907-1911.
58. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-965.
59. Winkler C, Modi W, Smith MW et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-393.
60. Marquet S, Abel L, Hillaire D, Dessein A. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur J Hum Genet 1999; 7: 88-97.